Drugs / Pegylated interferon lambda (pegIFNλ)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01616524 | Jul 2012 → Jun 2014 | hepatitis C virus infection | Bristol-Myers Squibb | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pegylated interferon lambda (pegIFNλ) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01616524 ↗ |